Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.43 |
| ▸ | KCNQ4 | P56696 | 3/20 | 0.39 |
| ▸ | KCNQ5 | Q9NR82 | 3/20 | 0.39 |
| ▸ | CISD2 | Q8N5K1 | 1/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 5/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KCNQ3 | O43525 | 2/20 | 0.36 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.36 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30739735 | 0.85 | CYP17A1 (0.44) | CYP17A1KCNQ4KCNQ5RXFP1LMNA | |
| SCHEMBL7008829 | 0.82 | CYP17A1 (0.44) | CYP17A1KCNQ4KCNQ5AAK1RXFP1 | |
| SCHEMBL30641931 | 0.81 | CYP17A1 (0.40) | CYP17A1KCNQ4KCNQ5RXFP1LMNA | |
| SCHEMBL24731578 | 0.81 | CYP17A1 (0.40) | CYP17A1KCNQ4KCNQ5RXFP1LMNA | |
| SCHEMBL29286688 | 0.81 | RXFP1 (0.46) | CYP17A1KCNQ4KCNQ5RXFP1LMNA | |
| SCHEMBL29448807 | 0.81 | RXFP1 (0.46) | CYP17A1KCNQ4KCNQ5RXFP1LMNA | |
| SCHEMBL10187654 | 0.80 | CYP17A1 (0.43) | CYP17A1KCNQ4KCNQ5RXFP1LMNA | |
| SCHEMBL30641929 | 0.80 | ATR (0.46) | CYP17A1KCNQ4KCNQ5CISD2RXFP1 | |
| SCHEMBL24730477 | 0.80 | ATR (0.46) | CYP17A1KCNQ4KCNQ5CISD2RXFP1 | |
| SCHEMBL31607582 | 0.79 | CYP17A1 (0.43) | CYP17A1KCNQ4KCNQ5CISD2AAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059577-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS | ATAVISTIK BIO, INC. (US) | 2025-03-20 | — | — | WO | disclosed |